• Explore /
  • Poster
  • / Avelumab first-line (1L) maintenance + best supportive care (BSC) versus BSC alone in Asian patients with advanced urothelial carcinoma (UC): JAVELIN Bladder 100 subgroup analysis.

Avelumab first-line (1L) maintenance + best supportive care (BSC) versus BSC alone in Asian patients with advanced urothelial carcinoma (UC): JAVELIN Bladder 100 subgroup analysis.

Abstract Poster

Authors

null

Masatoshi Eto

Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan

Masatoshi Eto , Jae-Lyun Lee , Se Hoon Park , Norihiko Tsuchiya , Po-Jung SU , T.W. Chan , Chirag Jyotiker Desai , Alessandra Di Pietro , Jing Wang , Robert J Laliberte , Seasea Gao , Howard Gurney

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT02603432

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 486)

DOI

10.1200/JCO.2022.40.6_suppl.486

Abstract #

486

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Srikala S. Sridhar

First Author: Petros Grivas

First Author: Norihiko Tsuchiya

First Author: Thomas Powles